Muhammad Sheikh, MD

Fellow
Cardiology

    About me

    Gender

    Male

    Education & training

    Medical School
    Dow Medical College
    Resident Graduation Year
    2024

    Clinical trials

    Trial
    Internal Medicine

    VICTORION-2 PREVENT: A randomized double-blind, placebo-controlled, multicenter trial, assessing the impact of inclisiran on major adverse cardiovascular events in participants with established cardiovascular disease

    Active recruiting

    PURPOSE: The purpose of this clinical trial is to find out if the investigational study treatment, called inclisiran, can help prevent cardiovascular events (such as heart attacks, strokes, and cardiovascular-related deaths) in adults who already have been diagnosed with cardiovascular disease